
Arthrosamid Therapy for Moderate Knee Osteoarthritis to Delay Surgery and Sustain Activity
Arthrosamid offers a cutting-edge, non-surgical treatment for moderate knee osteoarthritis by using a biocompatible hydrogel injection that mimics natural cartilage cushioning. Designed to reduce pain and enhance joint function, this innovative approach can delay the need for knee replacement surgery, providing long-lasting symptom relief. Ideal for patients seeking alternatives to surgery, Arthrosamid is supported by clinical studies demonstrating safety and efficacy, particularly when combined with personalized care plans. Led by experts like Professor Paul Lee at the London Cartilage Clinic, patients receive professional guidance to optimize outcomes alongside physiotherapy and lifestyle adjustments. This promising therapy represents a valuable bridge for maintaining mobility and quality of life in knee OA management.




